Cell Therapeutics Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
2.61 Mil |
| Income |
-130.73 Mil |
| Net Profit Margin |
NA |
| Return on Equity |
NA |
| Debt/Equity Ratio |
NA |
|
| Revenue/Share |
0.01 |
| Earnings/Share |
-0.71 |
| Book Value/Share |
-0.02 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 0.0 | 3.4 | 0.0 |
| 2nd Qtr | 0.0 | 2.9 | 0.0 |
| 3rd Qtr | 0.0 | 2.6 | 0.0 |
| 4th Qtr | NA | 2.5 | 0.1 |
| Total | 0.1 | 11.4 | 0.1 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.05 | -$7.68 | -$7.65 |
| 2nd Qtr | -$0.06 | -$5.18 | -$6.53 |
| 3rd Qtr | -$0.09 | -$2.83 | -$10.91 |
| 4th Qtr | NA | -$0.51 | -$7.44 |
| Total | -$0.20 | -$16.20 | -$32.53 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 90% | -3% | --- |
| 2nd Qtr | -20% | 33% | 15% |
| 3rd Qtr | -50% | 45% | -67% |
| 4th Qtr | NA | 82% | 32% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | 99% | 0% |
| 2nd Qtr | 99% | 21% |
| 3rd Qtr | 97% | 74% |
| 4th Qtr | NA | 93% |
advertisement
Recent News